AI-generated summary
This narrative mini-review examines visual-light exposure and locally applied red or near-infrared LED photobiomodulation for pain. The authors report that green light has generally produced antinociceptive effects in preclinical studies, while red light exposure has mostly been associated with increased pain, and local red or near-infrared LEDs have reduced pain in several preclinical models and limited clinical studies. The authors note that evidence is limited by heterogeneous protocols and small clinical samples.
- Who or what was studied
- unclear
- Limits stated in the abstract
- The abstract notes heterogeneous protocols, small clinical samples, and incomplete dosimetric reporting, and describes the work as a narrative mini-review.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Chronic pain remains a major clinical challenge, creating a need for safe, non-pharmacological interventions. This narrative mini-review examines two light-based approaches that differ in their sites of action and treatment parameters: visual-light exposure and local red or near-infrared light-emitting diode photobiomodulation. Visual-light exposure acts through retinal and central neural circuits, including pathways involving the ventrolateral geniculate nucleus, dorsal raphe nucleus, periaqueductal gray, medial secondary visual cortex, and anterior cingulate cortex. Its effects are wavelength- and context-dependent. Green light has generally produced antinociceptive effects in preclinical studies and preliminary clinical benefits in migraine, whereas visual exposure to red light has predominantly been associated with increased pain. White light can either facilitate or suppress pain depending on irradiance, exposure duration, circadian timing, and clinical context. By contrast, locally applied red or near-infrared LEDs have reduced pain in several preclinical models and limited clinical studies through peripheral opioid signaling, modulation of nitric oxide and nociceptor sensitization, and anti-inflammatory and antioxidant effects. The opposing effects of visual and local red light indicate that wavelength alone does not determine the pain response; exposure route, target tissue, dose, timing, and baseline pain state are also critical. Although visual-light interventions and local LED PBM appear promising as adjuncts to conventional treatment, the evidence remains limited by heterogeneous protocols, small clinical samples, and incomplete dosimetric reporting. Future studies should use standardized parameters, rigorous controls, and condition-specific protocols to establish efficacy and identify patients most likely to benefit.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Light-emitting diode, Near-infrared, Wavelength, Nitric oxide, Irradiance, Migraine, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.